1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. JUBILANT PHARMOVA LTD.
Jubilant Pharmova Ltd. NSE: JUBLPHARMA | BSE: 530019
1165.70 -6.10 (-0.52%)
146.5K
NSE+BSE Volume

NSE 11 Jul, 2025 3:31 PM (IST)

Dividend
Jubilant Pharmova Ltd. has an upcoming dividend of ₹5.00 per share due on 25 Jul 2025 See details
MF Feb-2021 Jan-2021 Dec-2020
AUM (Rs Cr) AUM % Shares Held Month Change in Shares Month Change in Shares % Shares Held Month Change in Shares % Shares Held Month Change in Shares %
Quant Aggressive Hybrid Fund Growth 0.20 1.25% 2,600 0 0% 2,600 136.36% 1,100 100%
ICICI Prudential BSE 500 ETF 0 -% 0 -417 -100% 417 0% 417 0%
DSP Healthcare Fund Regular Growth - -% - - -% - -% 307,556 0%
LIC MF Healthcare Fund Regular Growth 0 -% 0 -10,940 -100% 10,940 0% 10,940 0%
Quant ELSS Tax Saver Growth 1.30 1.97% 16,880 0 0% 16,880 84.88% 9,130 100%
DSP Large & Mid Cap Fund Growth - -% - - -% 0 -100% 600,537 -24.17%
Quant Large and Mid Cap Fund Growth 0.56 5.29% 7,220 0 0% 7,220 2574.07% 270 100%
Quant ESG Equity Fund Regular Growth 0.26 1.96% 3,350 0 0% 3,350 91.43% 1,750 100%
Quant Multi Cap Fund Growth 3.84 1.90% 49,950 0 0% 49,950 41.90% 35,200 100%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular Growth 1.28 0.95% 16,659 849 5.37% 15,810 12.53% 14,049 25.00%
Shriram Balanced Advantage Fund Regular Growth 0 -% 0 -6,661 -100% 6,661 -23.97% 8,761 0%
Shriram Aggresive Hybrid Fund Regular Growth 0.62 1.06% 8,030 -5,092 -38.81% 13,122 -22.50% 16,931 0%
Shriram Flexi Cap Fund Regular Growth 0 -% 0 -12,856 -100% 12,856 -28.82% 18,061 0%
Shriram ELSS Tax Saver Fund Regular Growth 0.57 1.62% 7,438 -999 -11.84% 8,437 0% 8,437 0%
Quant Mid Cap Fund Growth 1.70 5.45% 22,050 0 0% 22,050 109.00% - -%
Quant Multi Asset Allocation Fund Growth 0 -% 0 -6,000 -100% 6,000 100% - -%
Nippon India Pharma Fund - Growth 69.63 1.67% 904,802 0 0% 904,802 100% - -%
Nippon India Multi Cap Fund - Growth 15.59 0.17% 202,620 -100,000 -33.04% 302,620 100% - -%
Total: 1,241,599 -142,116 1,383,715 1,033,139